从2014年欧洲肿瘤内科学会指南再看结直肠癌肝转移规范化诊治进展  

Rethinking the standardization and advances in diagnosis and treatment of colorectal liver metastases from ESMO Clinical Practice Guidelines for Metastatic Colorectal Cancer

作　　者：姚宏伟[1] 修典荣[1] 

机构地区：[1]北京大学第三医院普通外科,北京100191

出　　处：《中国实用外科杂志》2015年第10期1040-1045,共6页Chinese Journal of Practical Surgery

基　　金：国家临床重点建设专科项目基金[卫办医政函(2012)650号]

摘　　要：结直肠癌肝转移(CLM)是结直肠癌病人最为常见的远处转移部位以及最主要的死亡原因。近年来,随着诊治理念的更新,越来越多的CLM病人获得手术治疗的机会并且预后得以改善。基于循证医学的证据,2014年欧洲肿瘤内科学会(ESMO)发布了《ESMO转移性结直肠癌的诊断、治疗和随访临床实践指南》,推荐对CLM进行规范化诊断和治疗,这包括多学科团队协作诊治、准确评估CLM的可切除性、积极的手术治疗、恰当的综合治疗方案以及个体化的药物治疗。Colorectal liver metastases （CLM） is the most common site of distant metastases and one of the most common leading causes in patients of colorectal cancer. In recent years, along with the updatingconeept of diagnosis and treatment, more and more patients of CLM received surgical treatment opportunities and improved survival. Based on evidence-based medicine, clinical practice guidelines for metastatic colorectal cancer was released by European Society for Medical Oneology in 2014.Standardized strategy of diagnosis and treatment for CLM was recommended, which included diagnosis and treatment by muhidisciplinary team,accurate evaluation of the resectability, resection, proper comprehensive treatment medicine for CLM.

关 键 词：结直肠癌肝转移 多学科团队 可切除性 个体化治疗 

分 类 号：R6[医药卫生—外科学]